article thumbnail

Associations of triglyceride-glucose (TyG) index with chest pain incidence and mortality among the U.S. population

Cardiovascular Diabetology

The triglyceride and glucose (TyG) index, a simple surrogate marker of insulin resistance, is related to cardiovascular disease. However, there is a lack of evidence for the relationship between the TyG index.

article thumbnail

Cardiovascular disease development in COVID-19 patients admitted to a tertiary medical centre in Iran

The British Journal of Cardiology

Cardiovascular diseases (CVDs) have been reported to occur in a significant number of patients diagnosed with coronavirus disease 2019 (COVID-19). Cardiovascular consultation had been requested for all of the patients based on their primary clinical examination, vital signs, and electrocardiogram (ECG).

article thumbnail

Multimorbidity Patterns and In‐Hospital Outcomes in Chinese Young Women (Aged <55 Years) Presenting with ST‐Segment–Elevation Myocardial Infarction

Journal of the American Heart Association

years]) admitted to the China Chest Pain Center Database between 2016 and 2021. Hierarchical clustering of 15 medical conditions was performed to derive multimorbidity patterns. The primary outcome was a composite of inhospital adverse events.

article thumbnail

A Relatively Narrow Complex Tachycardia at a Rate of 180.

Dr. Smith's ECG Blog

Marcus, G. Harvard Medical School, Boston, Massachusetts, USA. Metoprolol and atenolol are overwhelmingly beta-1 cardioselective. Beta-1 blockade decreases inotropy and chronotropy and has no vasoconstrictive effects. Only beta-2 blockade (e.g., Hollander, J. de Lemos, J. Gibler, W. Philippides, G. Henry Ford Hospital. Hollander, J. de Lemos, J.

article thumbnail

American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary

DAIC

Clinical and Investigative Horizons (Session 410) Sunday, April 7 4:30 – 5:45 p.m.

article thumbnail

Rise of COVID's JN.1 Sub variant Cases in India in 2023

Wellnest

Risk of Cardiovascular Disease by COVID-19 Can COVID-19 damage the heart? Yes, COVID-19, primarily a respiratory disease, can affect the heart. Yes, COVID-19 symptoms can resemble a heart attack, including chest pain, shortness of breath, and changes in echocardiogram or EKG. Risk posed by JN.1

article thumbnail

Abstract 151: Age?Related Increases in Carotid Artery Calcification: Insights from NaF PET/CT Imaging

Stroke: Vascular and Interventional Neurology

The gradual loss of elasticity in arterial walls and the presence of other risk factors, such as high blood pressure and diabetes, contribute to the increased risk of cardiovascular disease (CVD) observed in aging populations. years, 50% males) with known cardiovascular risk factors underwent FDG‐PET/CT.